F 0760
Ensure that residents are free from significant medication errors.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
medical record review, resident interview, staff interview, and review of the facility policy, the facility failed to
ensure residents were free from significant medication errors. This affected two (Residents #40 and #197)
of eight residents reviewed for medications administration. The facility census was 50.
Residents Affected - Few
Findings include:
1. Review of the medical record for Resident #197 revealed an admission date of 06/08/24 with diagnoses
including orthostatic hypotension, methicillin-resistant staphylococcus aureus (MRSA) bacteremia,
persistent postprocedural fistula, and chronic obstructive pulmonary disease (COPD).
Review of the admission assessment for Resident #197 dated 06/08/24 revealed the resident was
cognitively intact, had a current infection, and received an intravenous (IV) medication.
Review of the hospital discharge summary for Resident #197 dated 06/08/24 revealed an order for
daptomycin (an antibiotic) IV 940 milligrams (mg) daily for six weeks.
Review of the June 2024 monthly physician orders for Resident #197 revealed a physician order dated
06/10/24 for daptomycin 940 mg IV daily.
Review of the Medication Administration Record (MAR) for Resident #197 dated June 2024 revealed
daptomycin IV was administered as ordered starting on 06/10/24. The medication was not administered on
06/08/24 or 06/09/24.
Interview on 06/10/24 at 10:09 A.M. with Resident #197 confirmed he admitted to the facility on [DATE] and
was supposed to receive IV medication daily for an infection, but he hadn't received any medication through
his peripherally inserted central catheter (PICC) since he left the hospital.
Interview on 06/12/24 at 9:33 A.M. with DON confirmed the hospital Discharge summary dated [DATE]
included an order for daptomycin 940 mg IV daily. The DON confirmed the facility did not order or
administer the medication until 06/10/24 which was an error of omission for daptomycin on 06/08/24 and
06/09/24.
Interview on 06/12/24 at 9:37 A.M. with Licensed Practical Nurse (LPN) #127 confirmed she was notified
per verbal report from night shift nurse on the morning of 06/10/24 that Resident #197 was supposed to
receive an IV antibiotic but did not see an order for the medication. LPN #127 stated she reviewed Resident
#197's medical record and saw the order for daptomycin in the hospital discharge summary, entered the
ordered into the electronic medical record, and ordered the medication from the
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
366461
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366461
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/13/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Wooded Glen
2900 Bechtle Avenue
Springfield, OH 45504
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
pharmacy. LPN #127 confirmed she administered the daptomycin 940 mg IV to Resident #197 via PICC
line on 06/10/24 as ordered.
2. Review of the medical record for Resident #04 revealed an admission date of 08/30/21 with diagnoses
including hypertensive heart disease, congestive heart failure, chronic respiratory failure, COPD, and
diabetes mellitus.
Review of the annual Minimum Data Set (MDS) assessment for Resident #04 dated 03/06/24 revealed the
resident was cognitively intact and required staff assistance with bathing and toilet hygiene and supervision
with bed mobility and transfers.
Review of the progress note for Resident #04 dated 12/07/23 timed at 3:04 P.M. per the nurse practitioner
(NP) revealed Aldactone (a diuretic medication) should be discontinued due to hyperkalemia (a high level of
potassium in the blood.).
Review of the pharmacy recommendation for Resident #04 dated 12/15/24 revealed the NP progress note
dated 12/07/24 stated the Aldactone should be discontinued but the resident was still receiving the
medication. The pharmacy recommendation was for staff to clarify the order.
Review of the physician's orders for Resident #04 revealed an order dated 12/20/24 to discontinue
Aldactone.
physician order dated 09/23/23 for Aldactone 25 milligram (mg) by mouth one tab daily. Review of a
physician order dated 12/20/23 revealed the Aldactone was discontinued.
Review of the MAR for Resident #04 dated December 2023 revealed the received Aldactone by mouth daily
until 12/20/24.
Interview on 06/13/24 at 9:15 A.M. with the Director of Nursing (DON) confirmed the NP intended for the
staff to discontinue Resident #04's Aldactone on 12/07/24, but it was not discontinued until 12/20/24. The
medication was administered in error from 12/07/24 to 12/20/24.
Review of the facility policy titled Medication Administration revised November 2018 revealed medications
were to be administered in accordance with the written orders of the prescriber.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366461
If continuation sheet
Page 2 of 2